BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 757312)

  • 1. New concepts on the interference of alkylating antitumor agents with the regulation of cell division.
    Grunicke H; Gantner G; Holzweber F; Ihlenfeldt M; Puschendorf B
    Adv Enzyme Regul; 1978; 17():291-305. PubMed ID: 757312
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of alkylating antitumor agents on the binding of DNA to protein.
    Grunicke H; Bock KW; Becher H; Gäng V; Schnierda J; Puschendorf B
    Cancer Res; 1973 May; 33(5):1048-53. PubMed ID: 4349930
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of the alkylating antitumor agent 2,3,5-tris(ethyleneimino)benzoquinone with the plasma membrane of Ehrlich ascites tumor cells.
    Ihlenfeldt M; Gantner G; Harrer M; Puschendorf B; Putzer H; Grunicke H
    Cancer Res; 1981 Jan; 41(1):289-93. PubMed ID: 6256062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of thymidine transport at low doses of the alkylating agents triethyleneiminobenzoquinone (Trenimon).
    Grunicke H; Hirsch F; Wolf H; Bauer U; Kiefer G
    Exp Cell Res; 1975 Feb; 90(2):357-64. PubMed ID: 1112277
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacodynamic effect of alkylating cytostatics].
    Maass H
    Dtsch Med J; 1968 Mar; 19(5):137-41. PubMed ID: 4887779
    [No Abstract]   [Full Text] [Related]  

  • 6. Depression of the intracellular histone messenger RNA content by the alkylating agent 2,3,5-trisethyleneiminobenzoquinone.
    Raydt G; Holzweber F; Puschendorf B; Grunicke H
    FEBS Lett; 1977 Feb; 74(1):111-4. PubMed ID: 838068
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Effect of triethyleneiminobenzoquinone (trenimon) on thymidine transport in Ehrlich ascites tumor cells.
    Hirsch F; Wolf H; Grunicke H
    Hoppe Seylers Z Physiol Chem; 1974 Oct; 355(10):1208. PubMed ID: 4477748
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of tumor growth by an alkylation of the plasma membrane.
    Grunicke H; Grünewald K; Helliger W; Scheidl F; Wolff-Schreiner E; Puschendorf B
    Adv Enzyme Regul; 1983; 21():21-30. PubMed ID: 6100583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma membrane as target of alkylating agents.
    Grunicke H; Doppler W; Hofmann J; Lindner H; Maly K; Oberhuber H; Ringsdorf H; Roberts JJ
    Adv Enzyme Regul; 1985; 24():247-61. PubMed ID: 2940819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the mechanism of action of endoxan].
    Grunicke H; Liersch M; Holzer H; Arnold H
    Biochem Pharmacol; 1965 Nov; 14(11):1485-90. PubMed ID: 4286382
    [No Abstract]   [Full Text] [Related]  

  • 11. Different uptake of two alkylating substances by ascites tumor cells.
    Schmidt H; Liss E
    Arzneimittelforschung; 1978; 28(11):2150-2. PubMed ID: 582920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression of histone acetylation by alkylating antitumor agents in murine cells.
    Zwierzina H; Loidl A; Fuith LC; Helliger W; Puschendorf B; Grunicke H
    Cancer Res; 1984 Aug; 44(8):3336-9. PubMed ID: 6744267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vivo studies on the effect of Trenimon (I). Changes of biochemical parameters and inhibition of cell proliferation of Ehrlich ascites tumor cells].
    Liss E; Palme G; Oeff K
    Z Krebsforsch; 1968; 71(1):89-97. PubMed ID: 4299349
    [No Abstract]   [Full Text] [Related]  

  • 14. Depression of histone acetylation by alkylating antitumor agents: significance for antitumor activity and possible biological consequences.
    Grunicke H; Csordas A; Helliger W; Hauptlorenz S; Loidl A; Multhaup I; Zwierzina H; Puschendorf B
    Adv Enzyme Regul; 1984; 22():433-46. PubMed ID: 6475641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hydroxyurea and trisethyleneiminobenzoquinone (Trenimon) on the methylation of DNA in Ehrlich ascites tumor cells.
    Puschendorf B; Grunicke H
    Biochim Biophys Acta; 1972 Jun; 272(1):16-21. PubMed ID: 5043710
    [No Abstract]   [Full Text] [Related]  

  • 16. THE EFFECTS OF THE ALKYLATING CYTOSTATIC AGENT, 2,3,5-TRISETHYLENEIMINO-BENZOQUINONE-1,4(TRENIMON), ON THE PRIMING ABILITY OF DNA FROM MOUSE-ASCITES-TUMOR CELLS IN THE RNA-POLYMERASE-SYSTEM.
    GRUNICKE H; ZIMMERMANN F; HOLZER H
    Biochem Biophys Res Commun; 1965 Feb; 18():319-24. PubMed ID: 14300741
    [No Abstract]   [Full Text] [Related]  

  • 17. [Elimination of I-cells by alkylating cytostatics and their effects on the embryonal development of Hydractinia echniata].
    Müller W
    Exp Cell Res; 1968 Feb; 49(2):448-58. PubMed ID: 4106457
    [No Abstract]   [Full Text] [Related]  

  • 18. [Different influence on the incorporation of radioactive labeled thymidine into the DNA and DNA synthesis using the alkylizing cytostaticum 2,3,5-(trisethyelene-imino)-p-benzoquinone (trenimon)].
    Grunicke H; Hirsch F; Wolf H
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):710-1. PubMed ID: 5069282
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of the alkylating agent trisethyleneiminobenzoquinone (trenimon) on the template activity of chromatin and DNA in RNA and DNA polymerase systems.
    Puschendorf B; Wolf H; Grunicke H
    Biochem Pharmacol; 1971 Nov; 20(11):3039-50. PubMed ID: 4943597
    [No Abstract]   [Full Text] [Related]  

  • 20. [On various points of application of trenimon and mitomen in nucleic acid metabolism of tumor cells. (Studies with 3H-thymidine, 3H-cytidine and 32P)].
    Liss E; Palme G; Oeff K
    Nucl Med (Stuttg); 1965; 2():55-61. PubMed ID: 5888980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.